153 related articles for article (PubMed ID: 37085598)
1. Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.
Forker LJ; Bibby B; Yang L; Lane B; Irlam J; Mistry H; Khan M; Valentine H; Wylie J; Shenjere P; Leahy M; Gaunt P; Billingham L; Seddon BM; Grimer R; Robinson M; Choudhury A; West C
Br J Cancer; 2023 Jun; 128(12):2307-2317. PubMed ID: 37085598
[TBL] [Abstract][Full Text] [Related]
2. The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Forker L; Gaunt P; Sioletic S; Shenjere P; Potter R; Roberts D; Irlam J; Valentine H; Hughes D; Hughes A; Billingham L; Grimer R; Seddon B; Choudhury A; Robinson M; West CML
Br J Cancer; 2018 Mar; 118(5):698-704. PubMed ID: 29235571
[TBL] [Abstract][Full Text] [Related]
3. A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma.
Aggerholm-Pedersen N; Sørensen BS; Overgaard J; Toustrup K; Baerentzen S; Nielsen OS; Maretty-Kongstad K; Nordsmark M; Alsner J; Safwat A
Br J Cancer; 2016 Oct; 115(9):1096-1104. PubMed ID: 27701385
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
[TBL] [Abstract][Full Text] [Related]
5. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
6. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.
Ong CHC; Lee DY; Lee B; Li H; Lim JCT; Lim JX; Yeong JPS; Lau HY; Thike AA; Tan PH; Iqbal J
Breast Cancer Res; 2022 Jun; 24(1):38. PubMed ID: 35659359
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
[TBL] [Abstract][Full Text] [Related]
9. New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.
Scott DW; Abrisqueta P; Wright GW; Slack GW; Mottok A; Villa D; Jares P; Rauert-Wunderlich H; Royo C; Clot G; Pinyol M; Boyle M; Chan FC; Braziel RM; Chan WC; Weisenburger DD; Cook JR; Greiner TC; Fu K; Ott G; Delabie J; Smeland EB; Holte H; Jaffe ES; Steidl C; Connors JM; Gascoyne RD; Rosenwald A; Staudt LM; Campo E; Rimsza LM;
J Clin Oncol; 2017 May; 35(15):1668-1677. PubMed ID: 28291392
[TBL] [Abstract][Full Text] [Related]
10. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.
Pasquali S; Colombo C; Pizzamiglio S; Verderio P; Callegaro D; Stacchiotti S; Martin Broto J; Lopez-Pousa A; Ferrari S; Poveda A; De Paoli A; Quagliuolo V; Jurado JC; Comandone A; Grignani G; De Sanctis R; Palassini E; Llomboart-Bosch A; Dei Tos AP; Casali PG; Picci P; Gronchi A
Eur J Cancer; 2018 Apr; 93():28-36. PubMed ID: 29475197
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.
Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C
Front Immunol; 2021; 12():790661. PubMed ID: 34925373
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting.
Morris JS; Luthra R; Liu Y; Duose DY; Lee W; Reddy NG; Windham J; Chen H; Tong Z; Zhang B; Wei W; Ganiraju M; Broom BM; Alvarez HA; Mejia A; Veeranki O; Routbort MJ; Morris VK; Overman MJ; Menter D; Katkhuda R; Wistuba II; Davis JS; Kopetz S; Maru DM
Clin Cancer Res; 2021 Jan; 27(1):120-130. PubMed ID: 33109741
[TBL] [Abstract][Full Text] [Related]
13. Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts.
Yang L; Forker L; Irlam JJ; Pillay N; Choudhury A; West CML
Oncotarget; 2018 Jan; 9(3):3946-3955. PubMed ID: 29423096
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
Rühle A; Grosu AL; Wiedenmann N; Stoian R; Haehl E; Zamboglou C; Baltas D; Werner M; Kayser G; Nicolay NH
Radiother Oncol; 2021 Jun; 159():75-81. PubMed ID: 33753155
[TBL] [Abstract][Full Text] [Related]
15. A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.
Smyth EC; Nyamundanda G; Cunningham D; Fontana E; Ragulan C; Tan IB; Lin SJ; Wotherspoon A; Nankivell M; Fassan M; Lampis A; Hahne JC; Davies AR; Lagergren J; Gossage JA; Maisey N; Green M; Zylstra JL; Allum WH; Langley RE; Tan P; Valeri N; Sadanandam A
Ann Oncol; 2018 Dec; 29(12):2356-2362. PubMed ID: 30481267
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
17. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
[TBL] [Abstract][Full Text] [Related]
18. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
Winther M; Alsner J; Tramm T; Nordsmark M
Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
[TBL] [Abstract][Full Text] [Related]
20. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]